Evaluation of Chronic, Noncancer Pain Management Initiative in a Multidisciplinary Pain Clinic

被引:6
作者
Panicker, Latha [1 ,2 ]
Prasun, Marilyn A. [1 ]
Stockmann, Cherrill [1 ]
Simon, Jolene [2 ]
机构
[1] Illinois State Univ, Mennonite Coll Nursing, Normal, IL 61761 USA
[2] Edward Hines Jr VA Hosp, Hines, IL USA
关键词
OPIOIDS; REDUCTION; THERAPIES;
D O I
10.1016/j.pmn.2021.09.003
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Background: Chronic pain management is a major challenge for primary care providers (PCPs). PCPs manage many patients with chronic pain and other comorbidities including mental health problems like post-traumatic stress disorder (PTSD) and depression. Chronic pain and opioid problems are a national crisis, particularly among veterans (U.S. Department of Veterans Affairs, 2019). There are many veterans with chronic non-cancer pain who are being treated with opioids. Chronic opioid use has contributed to an epidemic of opioid-related adverse events (VA, 2017). Opioids not only result in poor pain control, but have associated risks such as misuse, overdose, and diversion which may be fatal (Frieden & Houry, 2016). Aims: The aim of this project was to evaluate chronic non-cancer pain management of veterans using an advanced practice registered nurse (APRN)-led multidisciplinary team approach to incorporate non-opioid and non-pharmacologic modalities to affect self-reported pain and use of prescribed opioids. Methods: A retrospective quality improvement (QI) project was conducted in the multidisciplinary pain (MDP) clinic. The APRN used a biopsychosocial approach for chronic pain management guided by the Plan, Do, Study, Act (PDSA) cycle framework. Thirty-four patients who were utilizing opioids for pain management were included using convenience sampling from the MDP clinic. The APRN educated and treated patients with non-opioid medications and non-pharmacolog therapies. A 10-point pain scale and morphine equivalent daily dose (MEDD) were utilized pre- and post-intervention to evaluate the MDP clinic. Results: Participants were predominantly male (91.8%), with a mean age of 63.18 +/- 15.39 years, and 36.4% of whom were retired. Only 20.6% of the participants reported the use of opioids for <12 months. Low back pain (93%) was the most common pain location. The mean baseline MEDD was 41.04 and the post tapered MEDD was 23.05; this revealed a significant decline in MEDD (p <.00 01). A decline was also found between pre- and post-pain scores (ranges 0-8). There was a significant reported decline in pain scores with a baseline of 6.11 to post tapering pain of 3.1 (t = 4.99, df = 28, p <.0 001). Participants preferred non-opioid medications 94% and non-pharmacologic therapy 86%, like physical therapy, yoga, and acupuncture. Fifty-one percent of patients were referred for injections and 46% were referred to primary care behavior health, which includes pain school, sleep hygiene classes, and cognitive behavior therapy. Conclusions: APRNs are in a key position to assess and treat patients based on current evidence while facilitating opioid titration. This initiative highlights that safe tapering of opioids is possible when utilizing a multidisciplinary approach for chronic pain management. Findings support the use of non-pharmacologic and non-opioid therapy for chronic pain management which can result in reduced patient-reported pain. Further research is warranted to examine both pharmacologic (non-opioid) and non-pharmacologic strategies that promote pain management while tapering opioids. Published by Elsevier Inc. on behalf of American Society for Pain Management Nursing.
引用
收藏
页码:122 / 127
页数:6
相关论文
共 33 条
[1]  
[Anonymous], 2016, CDC GUID PRESCR OP C
[2]   Time for change: an experimental investigation of chronic pain patients' emotional and attitudinal responses to simulated opioid-tapering advice [J].
Ashton-James, Claire E. ;
Chemke-Dreyfus, Axel ;
Costa, Daniel ;
Glare, Paul .
PAIN, 2019, 160 (07) :1586-1593
[3]  
CDC, 2018, CALC TOT DAIL DOS OP
[4]  
Centers for Disease Control and Prevention (CDC), 2020, COMPR LOOK DRUG OV U
[5]  
Centers for Disease Control and Prevention (CDC), 2019, MAN CHRON PAIN
[6]  
Centers for Disease Control and Prevention (CDC), 2019, INF PROV SAF PRESCR
[7]  
Chou Roger, 2014, Evid Rep Technol Assess (Full Rep), P1, DOI 10.23970/AHRQEPCERTA218
[8]   Opioids May be Appropriate for Chronic Pain [J].
Christo, Paul J. .
JOURNAL OF LAW MEDICINE & ETHICS, 2020, 48 (02) :241-248
[9]  
Costello M., 2016, MEDSURG Nursing, V25, P307
[10]  
Ding Y., 2020, Total expenses, total utilization, and sources of payment for outpatient prescription opioids in the U.S. adult civilian noninstitutionalized population